LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Fulgent Genetics Inc

Cerrado

SectorSalud

21.26 -2.25

Resumen

Variación precio

24h

Actual

Mínimo

21.14

Máximo

21.31

Métricas clave

By Trading Economics

Ingresos

-7.4M

-19M

Ventas

8.3M

82M

Margen de beneficio

-23.539

Empleados

1,313

EBITDA

-3.5M

-15M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+14.68% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

82M

631M

Apertura anterior

23.51

Cierre anterior

21.26

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Fulgent Genetics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 ago 2025, 16:11 UTC

Principales Movimientos del Mercado

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15 ago 2025, 22:22 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

15 ago 2025, 22:22 UTC

Charlas de Mercado

Target Is Falling Behind Its Peers -- Market Talk

15 ago 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

15 ago 2025, 20:33 UTC

Charlas de Mercado

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15 ago 2025, 20:25 UTC

Ganancias
Adquisiciones, fusiones, absorciones

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15 ago 2025, 20:24 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 ago 2025, 20:18 UTC

Ganancias

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 ago 2025, 19:14 UTC

Charlas de Mercado

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15 ago 2025, 19:12 UTC

Charlas de Mercado

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15 ago 2025, 18:32 UTC

Charlas de Mercado

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15 ago 2025, 17:33 UTC

Charlas de Mercado

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15 ago 2025, 17:23 UTC

Charlas de Mercado
Ganancias

Deere's Earnings Appear to Be Troughing -- Market Talk

15 ago 2025, 16:27 UTC

Ganancias

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15 ago 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

15 ago 2025, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

15 ago 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

15 ago 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15 ago 2025, 15:52 UTC

Adquisiciones, fusiones, absorciones

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15 ago 2025, 15:36 UTC

Charlas de Mercado

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15 ago 2025, 15:29 UTC

Ganancias

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15 ago 2025, 15:29 UTC

Adquisiciones, fusiones, absorciones

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15 ago 2025, 15:28 UTC

Ganancias

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15 ago 2025, 15:24 UTC

Charlas de Mercado

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15 ago 2025, 15:08 UTC

Charlas de Mercado

Applied Materials Is Losing Share in Chips Business -- Market Talk

15 ago 2025, 14:38 UTC

Adquisiciones, fusiones, absorciones

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15 ago 2025, 14:37 UTC

Adquisiciones, fusiones, absorciones

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15 ago 2025, 14:37 UTC

Adquisiciones, fusiones, absorciones

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15 ago 2025, 14:36 UTC

Adquisiciones, fusiones, absorciones

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15 ago 2025, 14:33 UTC

Adquisiciones, fusiones, absorciones

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Comparación entre iguales

Cambio de precio

Fulgent Genetics Inc Esperado

Precio Objetivo

By TipRanks

14.68% repunte

Estimación a 12 meses

Media 24.38 USD  14.68%

Máximo 30 USD

Mínimo 21 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fulgent Genetics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

17.32 / 19.04Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Neutral Evidence

Sentimiento

By Acuity

157 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.